On June 16, 2025, the IHU RespirERA had the honor of hosting an exceptional conference led by Professor Klaus Pantel, a world-renowned expert in the field of liquid biopsy.
A central topic in respiratory health and cancer care
Entitled "Liquid Biopsy: from discovery to clinical implementation", the conference provided an overview of key breakthroughs in this innovative approach, particularly in the monitoring of diseases such as lung cancer, a major focus for IHU RespirERA.
As President of the European Liquid Biopsy Society (ELBS), Prof. Pantel presented the results of 15 years of research that have led to the clinical integration of liquid biopsy in patient management. This non-invasive method now makes it possible to detect and monitor circulating tumor markers (cells, DNA, RNA) from a simple blood sample. It enables earlier diagnosis, improved disease monitoring, and better treatment adaptation.
A concrete example of precision medicine
This conference showcased how precision medicine tools are now being used to improve the management of serious respiratory diseases, especially lung cancer, a complex condition often diagnosed at an advanced stage.
With liquid biopsy, treatment strategies can be adjusted more precisely, relapse can be anticipated, and patient outcomes significantly improved.
Insightful discussions
Researchers, clinicians, students, and medical innovation stakeholders gathered to engage in enriching discussions with Prof. Pantel. The evening concluded with a convivial buffet, fostering further exchanges of knowledge.
IHU RespirERA continues to promote innovation in respiratory health by encouraging dialogue between cutting-edge research, clinical practice, and public health priorities.
